Dynamic Biosensors
Private Company
Total funding raised: $40.6M
Overview
Dynamic Biosensors is a privately held German company providing innovative tools for the biophysical analysis of molecular interactions, primarily serving the drug discovery and life sciences research markets. The company's proprietary switchSENSE® and scIC technologies enable real-time, label-free kinetic measurements for molecule-molecule and molecule-cell interactions with high sensitivity. Its product portfolio includes the heliX® series of biosensor instruments, specialized chips, and software, positioning it as a key enabler for researchers tackling complex biological questions in areas like targeted protein degradation and immunotherapy. The company appears to be in a revenue-generating stage, selling instruments and consumables to academic and industrial research labs globally.
Technology Platform
switchSENSE® (DNA nano-lever technology for molecule-molecule interaction analysis) and single-cell Interaction Cytometry (scIC) for real-time, label-free kinetic measurements on live cells.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive biophysical analysis and label-free detection market, competing against giants like Cytiva (Biacore SPR), Sartorius (Octet BLI), and Nicoya Lifesciences. Its differentiation lies in the unique combination of kinetics, sizing, and live-cell interaction analysis, carving out a niche for complex, mechanistic studies that simpler affinity-based technologies cannot address.